Segmental and global longitudinal strain measurement by 2-dimensional speckle tracking echocardiography in severe rheumatic mitral stenosis.
Left ventricular dysfunction
Mitral stenosis
Rheumatic Heart Disease
Strain measurement
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
23
02
2023
accepted:
20
11
2023
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
epublish
Résumé
The present study aimed to detect subtle left ventricular (LV) dysfunction in patients with severe rheumatic mitral stenosis (MS) by measuring global and segmental longitudinal strain with a two-dimensional speckle tracking echocardiography (2D-STE) method. In this case-control study, 65 patients with severe rheumatic MS and preserved ejection fraction (EF ≥ 50% measured by conventional echocardiographic methods) were compared with 31 otherwise healthy control subjects. All patients underwent LV strain measurement by the 2D-STE method in addition to conventional echocardiography using a VIVID S60 echocardiography device. Absolute strain values in myocardial segments 1-8, 10, and 12 (all basal, mid anterior, mid anteroseptal, mid inferior, and mid anterolateral segments) were significantly lower in patients with severe MS compared with the control group (P < 0.05 for all). The absolute global longitudinal strain (GLS) value was higher in the control group (-19.56 vs. -18.25; P = 0.006). After adjustment for age, gender, and systolic blood pressure, the difference in GLS between the two groups was as follows: mean difference=-1.16; 95% CI: -2.58-0.25; P = 0.110. In patients with severe rheumatic MS and preserved EF, the absolute GLS tended to be lower than healthy controls. Furthermore, the segmental strain values of LV were significantly lower in most of the basal and some mid-myocardial segments. Further studies are warranted to investigate the underlying pathophysiology and clinical implications of this subclinical dysfunction in certain segments of patients with severe rheumatic MS.
Sections du résumé
BACKGROUND
BACKGROUND
The present study aimed to detect subtle left ventricular (LV) dysfunction in patients with severe rheumatic mitral stenosis (MS) by measuring global and segmental longitudinal strain with a two-dimensional speckle tracking echocardiography (2D-STE) method.
METHODS
METHODS
In this case-control study, 65 patients with severe rheumatic MS and preserved ejection fraction (EF ≥ 50% measured by conventional echocardiographic methods) were compared with 31 otherwise healthy control subjects. All patients underwent LV strain measurement by the 2D-STE method in addition to conventional echocardiography using a VIVID S60 echocardiography device.
RESULTS
RESULTS
Absolute strain values in myocardial segments 1-8, 10, and 12 (all basal, mid anterior, mid anteroseptal, mid inferior, and mid anterolateral segments) were significantly lower in patients with severe MS compared with the control group (P < 0.05 for all). The absolute global longitudinal strain (GLS) value was higher in the control group (-19.56 vs. -18.25; P = 0.006). After adjustment for age, gender, and systolic blood pressure, the difference in GLS between the two groups was as follows: mean difference=-1.16; 95% CI: -2.58-0.25; P = 0.110.
CONCLUSION
CONCLUSIONS
In patients with severe rheumatic MS and preserved EF, the absolute GLS tended to be lower than healthy controls. Furthermore, the segmental strain values of LV were significantly lower in most of the basal and some mid-myocardial segments. Further studies are warranted to investigate the underlying pathophysiology and clinical implications of this subclinical dysfunction in certain segments of patients with severe rheumatic MS.
Identifiants
pubmed: 38012599
doi: 10.1186/s12872-023-03624-x
pii: 10.1186/s12872-023-03624-x
pmc: PMC10683114
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
584Informations de copyright
© 2023. The Author(s).
Références
Circulation. 1966 Sep;34(3):462-72
pubmed: 5922711
JACC Cardiovasc Imaging. 2018 Aug;11(8):1196-1201
pubmed: 30092974
Circulation. 2014 Jun 10;129(23):2440-92
pubmed: 24589852
Anatol J Cardiol. 2016 Oct;16(10):772-777
pubmed: 27182618
Circ Cardiovasc Imaging. 2019 Jul;12(7):e000027
pubmed: 31233331
Circulation. 2002 Jan 29;105(4):539-42
pubmed: 11815441
Echocardiography. 2020 Nov;37(11):1944-1950
pubmed: 32562447
BMC Neurol. 2021 Apr 1;21(1):145
pubmed: 33794796
Can J Cardiol. 2014 Sep;30(9):962-70
pubmed: 24986049
Heart. 2010 Dec;96(24):2032-40
pubmed: 21088126
Cardiovasc Ultrasound. 2012 May 29;10:23
pubmed: 22642798
BMC Med Imaging. 2015 Jul 25;15:25
pubmed: 26204938
Korean J Thorac Cardiovasc Surg. 2016 Oct;49(5):350-355
pubmed: 27733994
Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):316-25
pubmed: 26113121
J Cardiothorac Vasc Anesth. 2019 May;33(5):1315-1322
pubmed: 30581109
Cureus. 2022 Oct 22;14(10):e30573
pubmed: 36420250
Anadolu Kardiyol Derg. 2010 Aug;10(4):328-33
pubmed: 20693128
Int J Cardiovasc Imaging. 2022 Dec;38(12):2677-2686
pubmed: 36445667
Circulation. 2021 Feb 2;143(5):e72-e227
pubmed: 33332150
Cardiology. 2011;119(2):108-15
pubmed: 21912124
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):260-274
pubmed: 29413646
JACC Cardiovasc Imaging. 2018 Jan;11(1):15-24
pubmed: 28528147
Eur Heart J. 2003 Jul;24(13):1231-43
pubmed: 12831818
Heart Fail Clin. 2006 Oct;2(4):443-52
pubmed: 17448431
Clin Cardiol. 1994 Jun;17(6):330-6
pubmed: 8070151
J Cardiol. 2003 Aug;42(2):75-9
pubmed: 12964517
Anatol J Cardiol. 2016 Oct;16(10):778
pubmed: 27723667
Int J Cardiovasc Imaging. 2010 Apr;26(4):397-404
pubmed: 19967561
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):1-11
pubmed: 25525063
JACC Cardiovasc Imaging. 2014 Nov;7(11):1151-66
pubmed: 25459597
J Am Soc Echocardiogr. 2014 Jun;27(6):639-47
pubmed: 24637055
Eur Heart J. 2016 Apr 14;37(15):1196-207
pubmed: 26508168
Circulation. 1988 May;77(5):1013-21
pubmed: 3359583